ask="N/A"
ask_size="N/A"
average_daily_volume="594913"
bid="N/A"
bid_size="N/A"
book_value="11.38"
change="-3.82"
change_from_200_day_moving_average="1.27"
change_from_50_day_moving_average="-4.01"
change_from_52_week_high="-17.58"
change_From_52_week_low="22.67"
change_in_percent="-5.23%"
close="69.19"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-5.88"
ebitda="-230.87M"
eps_estimate_current_year="-6.14"
eps_estimate_next_quarter="-1.68"
eps_estimate_next_year="-6.72"
ex_dividend_date="N/A"
float_shares="37661000"
high="72.19"
high_52_weeks="86.77"
last_trade_date="1/17/2017"
last_trade_price="69.19"
last_trade_size="200"
last_trade_time="4:00pm"
low="69.03"
low_52_weeks="46.52"
market_capitalization="2.83B"
moving_average_200_day="67.92"
moving_average_50_day="73.20"
name="Ultragenyx Pharmaceutical Inc."
notes="N/A"
one_year_target_price="92.73"
open="72.19"
pe_ratio="N/A"
peg_ratio="-0.40"
percent_change_from_200_day_moving_average="+1.88%"
percent_change_from_50_day_moving_average="-5.47%"
percent_change_from_52_week_high="-20.26%"
percent_change_from_52_week_low="+48.73%"
previous_close="73.01"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.41"
price_per_sales="23305.59"
revenue="128000.00"
shares_outstanding="40859000"
short_ratio="10.26"
stock_exchange="NMS"
symbol="RARE"
volume="544897"
weeks_range_52="46.52 - 86.77"
